XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 26, 2022
Equity [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity for the three month period ended March 26, 2022 was as follows:

 

   Shares   Weighted Average Grant Fair Value 
Balance, December 25, 2021   2,077,592   $2.90 
Granted   37,100    2.36 
Forfeited   (7,100)   4.40 
Vested   (154,421)   2.73 
Balance, March 26, 2022   1,953,171   $2.90 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three months ended March 26, 2022 and March 27, 2021 (no tax benefits were recognized):

 

   Three Months Ended   Three Months Ended 
   March 26, 2022   March 27, 2021 
Cost of product revenues  $66,668   $133,784 
Research and development   147,379    94,053 
Selling, general and administrative   442,026    2,382,329 
Total  $656,073   $2,610,166